CERNEVIT multivitamin powder for injection vial, Baxter Healthcare Pty Ltd, CON-941
Product name
CERNEVIT multivitamin powder for injection vial
Sponsor name
Baxter Healthcare Pty Ltd
Consent start
Consent no.
CON-941
Duration
The consent is effective from 16 May 2022 until 3 September 2024.
Standard
Paragraph 10(4)(d) of Therapeutic Goods Order No. 91 - Standards for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The product does not conform to the requirements of Paragraph 10(4)(d) of TGO 91 - Standards for labels of prescription and related medicines, in that the product text height of the names of all active ingredients on vial labels is 1.5 mm, below the required text size of not less than 2.0 millimetres.
Conditions imposed
The labels to which this consent applies are those provided in the related request under s. 9D(3) for variation to the entry.
Import, Supply, &/or Export
Import, supply and export
Therapeutic product type
Prescription medicines